Oncogene-like addiction to aneuploidy in human cancers
- 👤 Speaker: Jason Sheltzer, Yale School of Medicine
- 📅 Date & Time: Monday 27 March 2023, 14:00 - 15:00
- 📍 Venue: CRUK CI Lecture Theatre
Abstract
Most cancers exhibit aneuploidy, but its functional significance in tumor development is controversial. We have developed ReDACT (Restoring Disomy in Aneuploid cells using CRISPR Targeting), a set of chromosome engineering tools that allow us to eliminate specific aneuploidies from cancer genomes. Using ReDACT, we created a panel of isogenic cells that have or lack common aneuploidies, and we demonstrate that trisomy of chromosome 1q is required for malignant growth in cancers harboring this alteration. Mechanistically, gaining chromosome 1q increases the expression of MDM4 and suppresses TP53 signaling, and we show that TP53 mutations are mutually-exclusive with 1q aneuploidy in human cancers. Thus, specific aneuploidies play essential roles in tumorigenesis, raising the possibility that targeting these “aneuploidy addictions” could represent a novel approach for cancer treatment.
Series This talk is part of the Seminars on Quantitative Biology @ CRUK Cambridge Institute series.
Included in Lists
- All CMS Events
- All Talks (aka the CURE list)
- Biology
- bld31
- Cambridge Centre for Data-Driven Discovery (C2D3)
- CamBridgeSens
- Cambridge talks
- CCC talks for website
- Chris Davis' list
- Computational and Systems Biology
- CRUK CI Lecture Theatre
- CRUK CI Seminars
- custom
- Graduate-Seminars
- Interested Talks
- Liam
- Life Science Interface Seminars
- Life Sciences
- Life Sciences
- ME Seminar
- my_list
- ndk22's list
- ob366-ai4er
- other talks
- PMRFPS's
- rp587
- School of Physical Sciences
- se393's list
- Seminars on Quantitative Biology @ CRUK Cambridge Institute
- sfm36
- Trust & Technology Initiative - interesting events
- yk449
Note: Ex-directory lists are not shown.
![[Talks.cam]](/static/images/talkslogosmall.gif)

Jason Sheltzer, Yale School of Medicine
Monday 27 March 2023, 14:00-15:00